← Every company

Sunshine Biopharma Inc SEC Filings

What Sunshine Biopharma Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

SBFM overview →
Filings on file
129
since Nov 14, 2016
Warning signs
23
latest Mar 31, 2026
Last results
Apr 9, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Mar 31, 2026
Late filing notice
NT 10-K
Read ↗
Sep 30, 2025
Auditor change
8-K
Read ↗
Mar 31, 2025
Late filing notice
NT 10-K
Read ↗
Aug 14, 2024
Late filing notice
NT 10-Q
Read ↗
Jun 7, 2024
Delisting notice or listing transfer
8-K
Read ↗
May 15, 2024
Late filing notice
NT 10-Q
Read ↗
May 8, 2024
Auditor change
8-K
Read ↗
May 6, 2024
Auditor change
8-K
Read ↗
Mar 1, 2024
Delisting notice or listing transfer
8-K
Read ↗
Mar 31, 2023
Late filing notice
NT 10-K
Read ↗
Mar 24, 2023
Delisting notice or listing transfer
8-K
Read ↗
Dec 9, 2022
Delisting notice or listing transfer
8-K
Read ↗
Aug 14, 2020
Late filing notice
NT 10-Q
Read ↗
May 15, 2020
Late filing notice
NT 10-Q
Read ↗
Mar 30, 2020
Late filing notice
NT 10-K
Read ↗
Aug 14, 2019
Late filing notice
NT 10-Q
Read ↗
May 14, 2019
Late filing notice
NT 10-Q
Read ↗
Mar 29, 2019
Late filing notice
NT 10-K
Read ↗
Nov 14, 2018
Late filing notice
NT 10-Q
Read ↗
Aug 14, 2018
Late filing notice
NT 10-Q
Read ↗
May 15, 2018
Late filing notice
NT 10-Q
Read ↗
Nov 13, 2017
Late filing notice
NT 10-Q
Read ↗
Mar 30, 2017
Late filing notice
NT 10-K
Read ↗

Source: Sunshine Biopharma Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on SBFM

Related datasets